Astrana Health Inc (ASTH)
Profitability ratios
Return on sales
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Gross profit margin | 4.42% | -54,481.69% | 14.42% | 24.10% | 7.66% |
| Operating profit margin | 6.19% | 5,453.19% | 12.72% | 10.34% | 5.83% |
| Pretax margin | 6.78% | 4,500.31% | 13.04% | 12.05% | 4.01% |
| Net profit margin | 4.44% | 2,362.50% | 8.93% | 4.84% | 2.54% |
Astrana Health Inc's profitability ratios show a fluctuating trend over the past five years. The gross profit margin has been inconsistent, with a significant negative margin in 2022, followed by a rebound to 4.42% in 2023. The operating profit margin has also been volatile, with a massive percentage in 2022 possibly indicating exceptional non-recurring items.
The pretax margin has shown a general upward trend, reaching 6.78% in 2023, indicating an improvement in the company's ability to generate profits before taxes. Similarly, the net profit margin has also increased over the years, suggesting better efficiency in controlling expenses and generating net income.
Overall, while there have been fluctuations in Astrana Health Inc's profitability ratios, the upward trends in pretax and net profit margins indicate improvements in the company's profitability and performance in recent years. Further analysis and understanding of the factors driving these fluctuations would be needed to provide a more detailed assessment of the company's financial health.
Return on investment
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 9.07% | 10.79% | 11.52% | 9.85% | 4.45% |
| Return on assets (ROA) | 6.51% | 4.68% | 8.09% | 4.61% | 1.94% |
| Return on total capital | 12.46% | 13.98% | 23.28% | 18.41% | 6.38% |
| Return on equity (ROE) | 9.89% | 8.33% | 15.38% | 11.39% | 7.37% |
Astrana Health Inc's profitability ratios show a fluctuating trend over the past five years.
Starting with Operating Return on Assets (Operating ROA), which indicates the company's ability to generate profits from its operating activities, we see a gradual decline from 11.52% in 2021 to 9.07% in 2023. This decline may raise concerns about the company's operational efficiency and effectiveness in utilizing its assets to generate income.
Return on Assets (ROA) provides an overall view of the company's profitability in relation to its total assets. Astrana Health Inc's ROA has shown mixed results, with a significant increase from 4.61% in 2020 to 8.09% in 2021, followed by a decrease to 6.51% in 2023. This indicates that while the company improved its asset utilization in 2021, it experienced some challenges in maintaining the same level of profitability in the subsequent years.
Return on Total Capital reflects the company's ability to generate returns for both equity and debt holders. Astrana Health Inc's return on total capital has been volatile, with a peak of 23.28% in 2021, followed by a slight decline to 12.46% in 2023. This suggests that the company may have experienced fluctuations in its capital structure or profitability over the years.
Lastly, Return on Equity (ROE) measures the returns generated on shareholders' equity. Astrana Health Inc's ROE has shown an upward trend overall, indicating improved profitability for equity holders. The ROE increased from 7.37% in 2019 to 9.89% in 2023, with fluctuations in between.
In conclusion, while Astrana Health Inc has demonstrated improvements in some profitability metrics such as ROE, the decline in Operating ROA and fluctuations in ROA and Return on Total Capital merit further investigation to understand the underlying reasons and implications for the company's financial performance.